Kalaris Therapeutics Stock Forecast

Hold candidate since Jun 17, 2026 Gain 3.74%

The Kalaris Therapeutics Inc stock price gained 3.74% on the last trading day (Thursday, 18th Jun 2026), rising from $4.55 to $4.72. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.38% from a day low at $4.55 to a day high of $4.80. The price has been going up and down for this period, and there has been a 1.29% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 83 thousand more shares were traded than the day before. In total, 166 thousand shares were bought and sold for approximately $781.57 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -30.09% during the next 3 months and, with a 90% probability hold a price between $2.68 and $3.58 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

KLRS Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 09, 2026, and so far it has risen 15.54%. Further rise is indicated until a new top pivot has been found. Kalaris Therapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Kalaris Therapeutics Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.83. On a fall, the stock will find some support from the short-term average at $4.39. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Kalaris Therapeutics Inc stock

Kalaris Therapeutics Inc finds support from accumulated volume at $4.65 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.245 between high and low, or 5.38%. For the last week, the stock has had daily average volatility of 7.32%.

Our recommended stop-loss: $4.52 (-4.26%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (KLRS) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Kalaris Therapeutics Inc to open at $4.69, and during the day (based on 14 day Average True Range), to move between $4.55 and $4.89, which gives a possible trading interval of +/-$0.347 (+/-7.62%) up or down from last closing price. If Kalaris Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 7.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.65 (1.48%) than the resistance at $5.39 (14.19%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Kalaris Therapeutics Inc stock A Buy?

Kalaris Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.639 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $4.69 ( 0.671%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk